APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Immune Globulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rabies Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchRabies Immune Globulin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Immune Globulin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Rabies Immune Globulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Immune Globulin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Immune Globulin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rabies Immune Globulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rabies Immune Globulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rabies Immune Globulin include Sichuan Yuanda Shuyang, Weiguang Bio, Shanghai RAAS, Sanofi, Shuanglin Bio, VINS, Kamada, Grifols and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rabies Immune Globulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Immune Globulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Immune Globulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rabies Immune Globulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Rabies Immune Globulin Segment by Company

Sichuan Yuanda Shuyang

Weiguang Bio

Shanghai RAAS

Sanofi

Shuanglin Bio

VINS

Kamada

Grifols

CSL Behring

CNBG

CBPO

Bharat Serum

Rabies Immune Globulin Segment by Type

ERIG

HRIG

Rabies Immune Globulin Segment by Application

Category II Exposure

Category III Exposure

Rabies Immune Globulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Immune Globulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rabies Immune Globulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rabies Immune Globulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rabies Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rabies Immune Globulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rabies Immune Globulin Industry Trends Table 2. Rabies Immune Globulin Industry Drivers Table 3. Rabies Immune Globulin Industry Opportunities and Challenges Table 4. Rabies Immune Globulin Industry Restraints Table 5. Global Rabies Immune Globulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rabies Immune Globulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rabies Immune Globulin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Rabies Immune Globulin Sales Market Share by Manufacturers Table 9. Global Rabies Immune Globulin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Rabies Immune Globulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rabies Immune Globulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rabies Immune Globulin Manufacturers, Product Type & Application Table 13. Global Rabies Immune Globulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rabies Immune Globulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ERIG Table 17. Major Manufacturers of HRIG Table 18. Global Rabies Immune Globulin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Rabies Immune Globulin Sales by Type (2021-2026) & (K Units) Table 20. Global Rabies Immune Globulin Sales by Type (2027-2032) & (K Units) Table 21. Global Rabies Immune Globulin Sales Market Share by Type (2021-2026) Table 22. Global Rabies Immune Globulin Sales Market Share by Type (2027-2032) Table 23. Global Rabies Immune Globulin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Rabies Immune Globulin Revenue by Type (2021-2026) & (K Units) Table 25. Global Rabies Immune Globulin Revenue by Type (2027-2032) & (K Units) Table 26. Global Rabies Immune Globulin Revenue Market Share by Type (2021-2026) Table 27. Global Rabies Immune Globulin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Category II Exposure Table 29. Major Manufacturers of Category III Exposure Table 30. Global Rabies Immune Globulin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Rabies Immune Globulin Sales by Application (2021-2026) & (K Units) Table 32. Global Rabies Immune Globulin Sales by Application (2027-2032) & (K Units) Table 33. Global Rabies Immune Globulin Sales Market Share by Application (2021-2026) Table 34. Global Rabies Immune Globulin Sales Market Share by Application (2027-2032) Table 35. Global Rabies Immune Globulin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Rabies Immune Globulin Revenue by Application (2021-2026) & (K Units) Table 37. Global Rabies Immune Globulin Revenue by Application (2027-2032) & (K Units) Table 38. Global Rabies Immune Globulin Revenue Market Share by Application (2021-2026) Table 39. Global Rabies Immune Globulin Revenue Market Share by Application (2027-2032) Table 40. Global Rabies Immune Globulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Rabies Immune Globulin Sales by Region (2021-2026) & (K Units) Table 42. Global Rabies Immune Globulin Sales Market Share by Region (2021-2026) Table 43. Global Rabies Immune Globulin Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Rabies Immune Globulin Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 47. North America Rabies Immune Globulin Sales by Country (2027-2032) & (K Units) Table 48. Europe Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 50. Europe Rabies Immune Globulin Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Rabies Immune Globulin Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Rabies Immune Globulin Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Rabies Immune Globulin Sales by Country (2027-2032) & (K Units) Table 57. Global Rabies Immune Globulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Rabies Immune Globulin Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Rabies Immune Globulin Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Rabies Immune Globulin Revenue Market Share by Region (2021-2026) Table 61. Global Rabies Immune Globulin Revenue Market Share by Region (2027-2032) Table 62. Sichuan Yuanda Shuyang Company Information Table 63. Sichuan Yuanda Shuyang Business Overview Table 64. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio Table 66. Sichuan Yuanda Shuyang Recent Development Table 67. Weiguang Bio Company Information Table 68. Weiguang Bio Business Overview Table 69. Weiguang Bio Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Weiguang Bio Rabies Immune Globulin Product Portfolio Table 71. Weiguang Bio Recent Development Table 72. Shanghai RAAS Company Information Table 73. Shanghai RAAS Business Overview Table 74. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shanghai RAAS Rabies Immune Globulin Product Portfolio Table 76. Shanghai RAAS Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi Rabies Immune Globulin Product Portfolio Table 81. Sanofi Recent Development Table 82. Shuanglin Bio Company Information Table 83. Shuanglin Bio Business Overview Table 84. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Shuanglin Bio Rabies Immune Globulin Product Portfolio Table 86. Shuanglin Bio Recent Development Table 87. VINS Company Information Table 88. VINS Business Overview Table 89. VINS Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. VINS Rabies Immune Globulin Product Portfolio Table 91. VINS Recent Development Table 92. Kamada Company Information Table 93. Kamada Business Overview Table 94. Kamada Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Kamada Rabies Immune Globulin Product Portfolio Table 96. Kamada Recent Development Table 97. Grifols Company Information Table 98. Grifols Business Overview Table 99. Grifols Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Grifols Rabies Immune Globulin Product Portfolio Table 101. Grifols Recent Development Table 102. CSL Behring Company Information Table 103. CSL Behring Business Overview Table 104. CSL Behring Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. CSL Behring Rabies Immune Globulin Product Portfolio Table 106. CSL Behring Recent Development Table 107. CNBG Company Information Table 108. CNBG Business Overview Table 109. CNBG Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. CNBG Rabies Immune Globulin Product Portfolio Table 111. CNBG Recent Development Table 112. CBPO Company Information Table 113. CBPO Business Overview Table 114. CBPO Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. CBPO Rabies Immune Globulin Product Portfolio Table 116. CBPO Recent Development Table 117. Bharat Serum Company Information Table 118. Bharat Serum Business Overview Table 119. Bharat Serum Rabies Immune Globulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Bharat Serum Rabies Immune Globulin Product Portfolio Table 121. Bharat Serum Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Rabies Immune Globulin Distributors List Table 125. Rabies Immune Globulin Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Rabies Immune Globulin Product Image Figure 2. Global Rabies Immune Globulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Immune Globulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rabies Immune Globulin Sales (2021-2032) & (K Units) Figure 5. Global Rabies Immune Globulin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rabies Immune Globulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ERIG Image Figure 9. HRIG Image Figure 10. Global Rabies Immune Globulin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Rabies Immune Globulin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rabies Immune Globulin Sales Market Share by Type (2021-2032) Figure 13. Global Rabies Immune Globulin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Rabies Immune Globulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rabies Immune Globulin Revenue Market Share by Type (2021-2032) Figure 16. Category II Exposure Image Figure 17. Category III Exposure Image Figure 18. Global Rabies Immune Globulin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Rabies Immune Globulin Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Rabies Immune Globulin Sales Market Share by Application (2021-2032) Figure 21. Global Rabies Immune Globulin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Rabies Immune Globulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Rabies Immune Globulin Revenue Market Share by Application (2021-2032) Figure 24. North America Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Rabies Immune Globulin Sales Market Share by Country (2021-2032) Figure 26. U.S. Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Rabies Immune Globulin Sales Market Share by Country (2021-2032) Figure 31. Germany Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Rabies Immune Globulin Sales Market Share by Country (2021-2032) Figure 38. China Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Rabies Immune Globulin Sales Market Share by Country (2021-2032) Figure 46. Brazil Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Rabies Immune Globulin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Rabies Immune Globulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Rabies Immune Globulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Rabies Immune Globulin Revenue (2021-2032) & (US$ Million) Figure 57. North America Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Rabies Immune Globulin Revenue (2021-2032) & (US$ Million) Figure 59. Europe Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Rabies Immune Globulin Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Rabies Immune Globulin Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Rabies Immune Globulin Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Rabies Immune Globulin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • ERIG
  • HRIG
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Sichuan Yuanda Shuyang
  • Weiguang Bio
  • Shanghai RAAS
  • Sanofi
  • Shuanglin Bio
  • VINS
  • Kamada
  • Grifols
  • CSL Behring
  • CNBG
  • CBPO
  • Bharat Serum

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rabies Immune Globulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rabies Immune Globulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rabies Immune Globulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rabies Immune Globulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rabies Immune Globulin Market Dynamics
  1. 2.1 Rabies Immune Globulin Industry Trends
  2. 2.2 Rabies Immune Globulin Industry Drivers
  3. 2.3 Rabies Immune Globulin Industry Opportunities and Challenges
  4. 2.4 Rabies Immune Globulin Industry Restraints
3 Rabies Immune Globulin Market by Manufacturers
  1. 3.1 Global Rabies Immune Globulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rabies Immune Globulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rabies Immune Globulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rabies Immune Globulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rabies Immune Globulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rabies Immune Globulin Manufacturers, Product Type & Application
  7. 3.7 Global Rabies Immune Globulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rabies Immune Globulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rabies Immune Globulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rabies Immune Globulin Tier 1, Tier 2, and Tier 3
4 Rabies Immune Globulin Market by Type
  1. 4.1 Rabies Immune Globulin Type Introduction
  2. 4.1.1 ERIG
  3. 4.1.2 HRIG
  4. 4.2 Global Rabies Immune Globulin Sales by Type
  5. 4.2.1 Global Rabies Immune Globulin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rabies Immune Globulin Sales by Type (2021-2032)
  7. 4.2.3 Global Rabies Immune Globulin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rabies Immune Globulin Revenue by Type
  9. 4.3.1 Global Rabies Immune Globulin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rabies Immune Globulin Revenue by Type (2021-2032)
  11. 4.3.3 Global Rabies Immune Globulin Revenue Market Share by Type (2021-2032)
5 Rabies Immune Globulin Market by Application
  1. 5.1 Rabies Immune Globulin Application Introduction
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Rabies Immune Globulin Sales by Application
  5. 5.2.1 Global Rabies Immune Globulin Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Rabies Immune Globulin Sales by Application (2021-2032)
  7. 5.2.3 Global Rabies Immune Globulin Sales Market Share by Application (2021-2032)
  8. 5.3 Global Rabies Immune Globulin Revenue by Application
  9. 5.3.1 Global Rabies Immune Globulin Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Rabies Immune Globulin Revenue by Application (2021-2032)
  11. 5.3.3 Global Rabies Immune Globulin Revenue Market Share by Application (2021-2032)
6 Global Rabies Immune Globulin Sales by Region
  1. 6.1 Global Rabies Immune Globulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Immune Globulin Sales by Region (2021-2032)
  3. 6.2.1 Global Rabies Immune Globulin Sales by Region (2021-2026)
  4. 6.2.2 Global Rabies Immune Globulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rabies Immune Globulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rabies Immune Globulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rabies Immune Globulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rabies Immune Globulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rabies Immune Globulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rabies Immune Globulin Revenue by Region
  1. 7.1 Global Rabies Immune Globulin Revenue by Region
  2. 7.1.1 Global Rabies Immune Globulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rabies Immune Globulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Rabies Immune Globulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Rabies Immune Globulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rabies Immune Globulin Revenue (2021-2032)
  8. 7.2.2 North America Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rabies Immune Globulin Revenue (2021-2032)
  11. 7.3.2 Europe Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rabies Immune Globulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rabies Immune Globulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rabies Immune Globulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Yuanda Shuyang
  2. 8.1.1 Sichuan Yuanda Shuyang Company Information
  3. 8.1.2 Sichuan Yuanda Shuyang Business Overview
  4. 8.1.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio
  6. 8.1.5 Sichuan Yuanda Shuyang Recent Developments
  7. 8.2 Weiguang Bio
  8. 8.2.1 Weiguang Bio Company Information
  9. 8.2.2 Weiguang Bio Business Overview
  10. 8.2.3 Weiguang Bio Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Bio Rabies Immune Globulin Product Portfolio
  12. 8.2.5 Weiguang Bio Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS Rabies Immune Globulin Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Rabies Immune Globulin Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Shuanglin Bio
  26. 8.5.1 Shuanglin Bio Company Information
  27. 8.5.2 Shuanglin Bio Business Overview
  28. 8.5.3 Shuanglin Bio Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shuanglin Bio Rabies Immune Globulin Product Portfolio
  30. 8.5.5 Shuanglin Bio Recent Developments
  31. 8.6 VINS
  32. 8.6.1 VINS Company Information
  33. 8.6.2 VINS Business Overview
  34. 8.6.3 VINS Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VINS Rabies Immune Globulin Product Portfolio
  36. 8.6.5 VINS Recent Developments
  37. 8.7 Kamada
  38. 8.7.1 Kamada Company Information
  39. 8.7.2 Kamada Business Overview
  40. 8.7.3 Kamada Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kamada Rabies Immune Globulin Product Portfolio
  42. 8.7.5 Kamada Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grifols Rabies Immune Globulin Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 CSL Behring
  50. 8.9.1 CSL Behring Company Information
  51. 8.9.2 CSL Behring Business Overview
  52. 8.9.3 CSL Behring Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CSL Behring Rabies Immune Globulin Product Portfolio
  54. 8.9.5 CSL Behring Recent Developments
  55. 8.10 CNBG
  56. 8.10.1 CNBG Company Information
  57. 8.10.2 CNBG Business Overview
  58. 8.10.3 CNBG Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CNBG Rabies Immune Globulin Product Portfolio
  60. 8.10.5 CNBG Recent Developments
  61. 8.11 CBPO
  62. 8.11.1 CBPO Company Information
  63. 8.11.2 CBPO Business Overview
  64. 8.11.3 CBPO Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CBPO Rabies Immune Globulin Product Portfolio
  66. 8.11.5 CBPO Recent Developments
  67. 8.12 Bharat Serum
  68. 8.12.1 Bharat Serum Company Information
  69. 8.12.2 Bharat Serum Business Overview
  70. 8.12.3 Bharat Serum Rabies Immune Globulin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bharat Serum Rabies Immune Globulin Product Portfolio
  72. 8.12.5 Bharat Serum Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rabies Immune Globulin Value Chain Analysis
  2. 9.1.1 Rabies Immune Globulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rabies Immune Globulin Production Mode & Process
  6. 9.2 Rabies Immune Globulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rabies Immune Globulin Distributors
  9. 9.2.3 Rabies Immune Globulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst